qtwbsfdr

CRO/Sponsor Articles

Innovations in Patient Matching

Aug 12, 2016

By Lisa Henderson

With the ever-present gap in ability to recruit patients into clinical trials, emerging solutions take different tactics to find the right patients and enroll them quickly.

Lean Outsourcing Models for Clinical Trials: Factors for Achieving Success

Aug 03, 2016

By Denise Calaprice, PhD, Mitchell Katz, PhD

In the shifting landscape of product development, the pharma and biotech arenas increasingly emphasize the need to use less internal R&D resources, increase efficiency, and reduce costs. One product development strategy is the utilization of lean outsourcing models for clinical studies.

Generic Drug Repurposing Clinical Trials

Jun 07, 2016

By Bruce Bloom, JD, DDS

Generic drug repurposing can often create medical solutions regardless of the supporting entity. “Unsolved” diseases can benefit from this strategy despite commercialization challenges.

BioCelerate for Preclinical Collaboration

Mar 08, 2016

By Moe Alsumidaie

Six TransCelerate Member Companies formed BioCelerate, a subsidiary to focus on identifying innovative solutions for operational challenges in the preclinical space.

Forum Discusses Continued Challenges with Trial Data Transparency

Jan 15, 2016

By Lisa Henderson

With global regulatory changes happening quickly and often, there is concern that sponsors need more robust systems to keep pace and have a global disclosure strategy in place.

CRO/Sponsor News

Bioclinica Enters Agreement to be Acquired by Cinven

Bioclinica has signed an agreement to be acquired by international private equity firm Cinven.

Pharma Start and H2O Clinical to Merge

CROs H2O Clinical and Pharma Start have announced a merger to continue providing biostatistics, data management, clinical operations and medical writing to the pharmaceutical, medical device and biotechnology industries.

Evidera to Join PPD

PPD announces the acquisition of Evidera, an evidence-based solutions provider.

Pharma Company Selects OmniComm Platform

OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BE clinic.

Pluristem Deploys Medidata Cloud Technology

Medidata announced that its cloud technology platform has been adopted by Israeli biotech, Pluristem Therapeutics.

lorem ipsum